Señales en vivo de TNGX | Maximiza tus Ganancias con Getagraph.com

VENDER 117535 min ago

@ $11.71

Emitido: 13 feb 2024 @ 15:42

Retorno: -35.01%

Señal anterior: feb 13 - 09:30

Señal anterior: Comprar

Retorno: -1.76 %

Live Chart Being Loaded With Signals

Commentary (3 may 2024 @ 16:00):

Stats
Volumen de hoy	330 699
Volumen promedio	613 856
Capitalización de mercado	812.25M
EPS	$0 ( 2024-03-25 )
Próxima fecha de ganancias	( $-0.310 ) 2024-05-14
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-7.05
ATR14	$0.00800 (0.11%)

Insider Trading

Date	Person	Action	Amount	type
2024-05-01	Mva Investors, Llc	Sell	75 000	Common Stock
2024-05-02	Mva Investors, Llc	Sell	75 000	Common Stock
2024-05-03	Mva Investors, Llc	Sell	60 000	Common Stock
2024-02-20	Third Rock Ventures Iv, L.p.	Sell	162 500	Common Stock
2024-02-06	Weber Barbara	Sell	4 681	Common Stock

INSIDER POWER
87.11
Last 93 transactions
Buy: 16 052 308 \| Sell: 875 313

Volumen Correlación

Largo: -0.01 (neutral)

Corto: -0.73 (moderate negative)

Signal:(58.905) Neutral

Tango Therapeutics, Inc. Correlación

10 Correlaciones Más Positivas
GSMG	0.949
CMLS	0.947
AADI	0.942
AKTX	0.938
DSWL	0.934
TTCF	0.93
DRUG	0.929
INTA	0.928
ACRX	0.928
AROW	0.927

10 Correlaciones Más Negativas
MORF	-0.946
CNCE	-0.937
TYHT	-0.934
INOD	-0.93
PLYA	-0.923
EPZM	-0.923
BZ	-0.921
LFMD	-0.918
MOTNU	-0.917
ITI	-0.914

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Tango Therapeutics, Inc. Correlación - Moneda/Commodity

0.21
( neutral )

0.04
( neutral )

0.00
( neutral )

-0.04
( neutral )

0.07
( neutral )

Tango Therapeutics, Inc. Finanzas

Annual	2023
Ingresos:	$36.53M
Beneficio Bruto:	$34.11M (93.39 %)
EPS:	$-1.080

FY	2023
Ingresos:	$36.53M
Beneficio Bruto:	$34.11M (93.39 %)
EPS:	$-1.080

FY	2022
Ingresos:	$24.86M
Beneficio Bruto:	$20.83M (83.80 %)
EPS:	$-1.230

FY	2021
Ingresos:	$37.04M
Beneficio Bruto:	$37.04M (100.00 %)
EPS:	$-3.49

Financial Reports:

No articles found.

Tango Therapeutics, Inc.

Tango Therapeutics, Inc., a biotechnology company, discovers and develops drugs for the treatment of cancer. Its lead program is TNG908, a synthetic lethal small molecule inhibitor of protein arginine methyltransferase 5 that is being developed as a treatment for cancers with methylthioadenosine phosphorylase deletions. The company also develops Ubiquitin-specific protease 1, an inhibitor to treat patients with BRCA1 or BRCA2-mutant cancers; and Target 3 for STK11-mutant cancers. Tango Therapeutics, Inc. has a strategic collaboration with Gilead Sciences, Inc. for the discovery, development, and commercialization of a pipeline of therapies for patients with cancer. The company was founded in 2017 and is based in Cambridge, Massachusetts.